TestCard
PrivateLast Round
Series B
Apr 20, 2022
Est. Valuation
$18M
Total Funding Raised
$17.54M
Company Overview
TestCard operates in Healthcare & Life Sciences and is based in Scarborough. Its latest recorded funding round was a Series B round in April 2022.
TestCard is a diagnostic equipment company that develops medical diagnostic technology designed to provide non-invasive at-home testing.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Telemedicine, Patient Engagement
Business Model
B2C
Customer Profile
Hardware Sales, Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TestCard Comparables
Compare TestCard with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Neomend | 80% | |
| Newfoundland Diagnostics | 79% | |
| Healthy.io | 78% |
For institutional investors. Book with your work email.
TestCard Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Apr 20, 2022 | ||||
| Series A | Oct 19, 2020 | ||||
| Seed | Sep 25, 2018 |
For institutional investors. Book with your work email.
TestCard Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Neo Ventures | Seed |
| West Hill Capital | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 20, 2022
Raised $10M with West Hill Capital
- Oct 19, 2020
$6M round led by West Hill Capital
For institutional investors. Book with your work email.
TestCard Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about TestCard's valuation, stock price, and market status.
Is TestCard a public or private company?
TestCard is a private company.
What is the current stock price of TestCard?
TestCard is a private company, so its shares have no public market price. Caplight tracks TestCard's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is TestCard worth (valuation)?
TestCard's valuation is estimated at $18.0M based on funding round data.
Can I buy TestCard stock?
TestCard shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was TestCard's last funding round?
TestCard's most recent funding round was Series B on April 20, 2022.
Who are the main investors in TestCard?
Key investors in TestCard include Neo Ventures, West Hill Capital.
Will TestCard IPO soon?
No public IPO plans have been announced for TestCard.
How can I track TestCard secondary market activity?
Caplight tracks bids, offers, and trades in TestCard's shares on secondary markets.